Endocrinology

New indicators for use in general practice will support the personalisation of care and prevent overtreatment for people with diabetes, NICE says.

Albiglutide - a glucagon-like peptide 1 receptor agonist -results in fewer cardiovascular events in people with type 2 diabetes and existing cardiovascular disease than treatment with placebo.

Recent analysis from Diabetes UK shows that less than half of over 40s eligible for an NHS Health Check in the last five years have actually received one. 

According to a new analysis from the British Heart Foundation, the number of people suffering heart attacks and strokes as a result of their diabetes will rise by 29% by 2035.

New PHE data has shown a decrease in deaths from hepatitis C, yet diagnoses of advanced liver disease and related cancers remain stable.

When patients with type 2 diabetes receive intensified, multifactorial treatment combining lifestyle modification and pharmacological therapy for modifiable risk factors, there is no significant increase in medical costs, compared to patients who receive conventional, multifactorial treatment, according to the study presented at the American Diabetes Association conference.

New research published in Experimental Physiology has suggested a 6-week CrossFit exercise programme can lead to improved control of blood sugar levels and decreased risk of heart disease in people with type 2 diabetes.

A large study from Aarhus University, Denmark, showed that for individuals diagnosed with diabetes, screening is associated with a reduction in healthcare costs due to fewer admissions and doctor's visits and a reduction in prescribed medication

Studies have found an association between insufficient sleep and the development of insulin resistance, one of the factors that cause type 2 diabetes.